(NP (NP (NN Regulation)) (PP (IN of) (NP (NP (DT the) (NN BZLF1) (NN promoter)) (PP (IN of) (NP (JJ Epstein-Barr) (NN virus))))) (PP (IN by) (NP (JJ second) (NNS messengers))) (PP (IN in) (NP (JJ anti-immunoglobulin-treated) (NN B) (NNS cells))) (. .))
(S (NP-SBJ (NP (NN Initiation)) (PP (IN of) (NP (DT the) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (JJ lytic) (NN cycle)))) (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT the) (NN BZLF1) (NN gene))))))) (. .))
(S (NP-SBJ-10 (NP (DT The) (NN BZLF1) (NN gene) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Zp)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN activated) (NP (-NONE- *-10)) (PP (IN by) (NP-LGS (NP (NN crosslinking)) (PP (IN of) (NP (NN cell) (NN surface) (NP (NP (NN immunoglobulin)) (PRN (-LRB- -LRB-) (NP (NN Ig)) (-RRB- -RRB-))))) (PP (IN with) (NP (JJ anti-Ig) (NN antibody))))) (PP (IN in) (NP (NN B) (NNS cells))) (, ,) (PP (RB even) (IN in) (DT the) (NN absence) (IN of) (NP (JJ other) (JJ viral) (NNS genes))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD identified) (NP (NP (JJ several) (JJ anti-Ig) (NN response) (NNS elements)) (PP (IN within) (NP (NN Zp))) (, ,) (SBAR (WHNP-11 (WDT which)) (S (NP-SBJ-12 (-NONE- *T*-11)) (VP (VBD were) (VP (ADVP (RB originally)) (VBN defined) (NP (-NONE- *-12)) (PP (IN as) (NP (NP (NP (NN 12-O-tetradecanoylphorbol-13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-))) (NN response) (NNS elements) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN ZI) (NNS repeats)) (CC and) (NP (NP (NN ZII)) (, ,) (NP (DT an) (JJ AP-1-like) (NN domain)))) (-RRB- -RRB-)))))))))) (. .))
(S (SBAR (IN Since) (S (NP-SBJ (JJ anti-Ig) (NN crosslinking)) (VP (VBZ leads) (PP (TO to) (NP-COOD (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ intracellular) (NN calcium) (NN level))))))))) (, ,) (NP-SBJ-13 (NN Zp)) (VP (VBD was) (VP (VBN tested) (NP (-NONE- *-13)) (PP (IN for) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (DT these) (JJ cellular) (NNS factors))))))) (. .))
(S (NP-SBJ (NP (NN Treatment)) (PP (IN with) (NP (NN calcium) (NN ionophore) (NN A23187)))) (VP (VBD increased) (NP (NN Zp) (NN activity))) (. .))
(S (SBAR-TMP (WHADVP-14 (WRB When)) (S (NP-SBJ-15 (DT the) (NN calcium) (NN ionophore)) (VP (VBD was) (VP (VBN used) (NP (-NONE- *-15)) (PP (IN in) (NN conjunction) (IN with) (NP (NP (NN TPA)) (, ,) (NP (DT a) (NN PKC) (NN activator)))) (ADVP (-NONE- *T*-14)))))) (, ,) (NP-SBJ-16 (DT the) (NN Zp) (NN induction)) (VP (VBD was) (ADVP (RB synergistically)) (VP (VBN enhanced) (NP (-NONE- *-16)))) (. .))
